scispace - formally typeset
F

Francis G. Spinale

Researcher at University of South Carolina

Publications -  469
Citations -  24683

Francis G. Spinale is an academic researcher from University of South Carolina. The author has contributed to research in topics: Heart failure & Ventricular remodeling. The author has an hindex of 84, co-authored 451 publications receiving 23239 citations. Previous affiliations of Francis G. Spinale include Biogen Idec & Veterans Health Administration.

Papers
More filters
Journal Article

Abstract 1102: Differential Effect of Wall Tension on Matrix Metalloproteinase Promoter Activation in the Thoracic Aorta

TL;DR: In this article, the authors examined whether MMP promoter activation would occur as a function of wall tension and found that selective MMP induction occurs at wall tension values concordant with hypertension and that a mechanical-molecular set point exists which triggers adverse remodeling within the vascular wall.
Journal ArticleDOI

727-4 Differential Effects of Chronic Angiotensin Converting Enzyme (ACE) Inhibition and Angiotensin II (AT-II) Receptor (AT1AT-II) Blockade on Myocyte Excitation and Contraction in Dilated Cardiomyopathy

TL;DR: ACEI during the progression of DCM improved MYO function whereas AT-BLOCK had selective effects on MYO electrophysiology, suggesting that ACEI and AT- BLOCK have unique and different mechanisms of action with cardiomyopathic disease.
Journal Article

Abstract 12431: Continuous Localized Monitoring of Plasmin Activity Identifies Differential and Regional Effects of the Serine Protease Inhibitor Aprotinin: Relevance to Antifibrinolytic Therapy

TL;DR: Using a large animal model and a continuous method to monitor regional PLact, these unique results demonstrated that an empirical aprotinin dosing protocol causes maximal and rapid suppression in the myocardium and kidney and in turn would likely increase the probability of off-target effects and adverse events.
Patent

Composition for modifying myocardial infarction expansion

TL;DR: A bioscaffolding can be formed within a post-myocardial infarct region sufficient to cause attenuation of a rate of myocardial Infarct expansion.